Pharmabiz

US FDA approves Innoviva’s Nuzolvence, a first-in-class, single-dose, oral antibiotic to treat uncomplicated urogenital gonorrhoea in adults?and adolescents

US FDA approves Innoviva’s Nuzolvence, a first-in-class, single-dose, oral antibiotic to treat uncomplicated urogenital gonorrhoea in adults?and adolescents: Waltham, Massachuse ...
Pharmabiz

IHH Healthcare sets for next phase of growth in India with successful closure of the open offer for Fortis Healthcare and Fortis Malar Hospitals

IHH Healthcare sets for next phase of growth in India with successful closure of the open offer for Fortis Healthcare and Fortis Malar Hospitals: Our Bureau, Bengaluru Monday, Dec ...
Pharmabiz

ICMR funds new clinical trial to test effective dosing strategy of high-cost cancer drug PARP inhibitor

ICMR funds new clinical trial to test effective dosing strategy of high-cost cancer drug PARP inhibitor: Our Bureau, Mumbai Monday, December 15, 2025, 17:10 Hrs [IST] Funded by th ...
Pharmabiz

MOC Cancer Care Centre hosts ONCO 3Sixty 2025 bringing together multi-oncology community

MOC Cancer Care Centre hosts ONCO 3Sixty 2025 bringing together multi-oncology community: Our Bureau, Mumbai Monday, December 15, 2025, 17:40 Hrs [IST] MOC Cancer Care & Research ...
Pharmabiz

Greenspace Herbs opens US base as global demand surges for 'Quantum Ayurveda'

Greenspace Herbs, the Bengaluru-based company has opened a full-scale US office in New Jersey. The expansion comes as international supplement brands rush to secure a supply of the company's ...